Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.5100
-0.0099 (-1.90%)
At close: Feb 23, 2026, 4:00 PM EST
0.5200
+0.0100 (1.96%)
After-hours: Feb 23, 2026, 4:00 PM EST
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $17.56 million as of February 23, 2026. Its market cap has decreased by -48.00% in one year.
Market Cap
17.56M
Enterprise Value
17.58M
1-Year Change
-48.00%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $17.56M, a decrease of -86.74%. That is a compound annual growth rate of -80.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 17.90M | -49.02% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 19.80M |
| Anebulo Pharmaceuticals | 19.29M |
| Klotho Neurosciences | 18.58M |
| Pasithea Therapeutics | 18.47M |
| Serina Therapeutics | 17.47M |
| FibroBiologics | 16.50M |
| Hoth Therapeutics | 16.29M |
| Lexaria Bioscience | 16.21M |